News & Events about Curevac.
Jon and Pete Najarian join forces to discuss and debate their favorite topics, including the hottest stock-specific news and sports!Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Rivian adopting Tesla's charging standard, Lilly's plans to acquire DICE ...
TÜBINGEN, GERMANY and BOSTON, USA / ACCESSWIRE / June 19, 2023 / CureVac N.V. (Nasdaq:CVAC), a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), today announced the voting results of...
TÜBINGEN, GERMANY / BOSTON, MA / ACCESSWIRE / February 7, 2023 / CureVac N.V. (NASDAQ:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), announced today that it intends...
CureVac recognized as a Top 100 innovator in acknowledgment of the company's innovative strength and extensive intellectual property portfolioThe company holds one of broadest intellectual property portfolios in mRNA technologyTÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / January 31...